Travel Vaccines Market Report 2026

Travel Vaccines Market Overview

• Travel Vaccines market size has reached to $5.09 billion in 2025 • Expected to grow to $8.16 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Surge In Travel And Tourism Drives Growth Of The Travel Vaccine Market • Market Trend: Innovative Travel Vaccines Prevent Hepatitis A For Travelers And Children • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the travel vaccines market include: • Hepatitis A (Segmentation By Disease) → Expected gain of $0.5 Billion • Diphtheria, Pertussis, And Tetanus (DPT) (Segmentation By Disease) → Expected gain of $0.27 Billion • Hepatitis B (Segmentation By Disease) → Expected gain of $0.23 Billion

What Is Covered Under Travel Vaccines Market?

Travel vaccines are vaccines to protect against diseases that are either indigenous to the country of origin or the country of destination. They function to safeguard travelers and stop the spread of disease both within and between nations. The main travel vaccines available to treat diseases include hepatitis A, diphtheria, pertussis, and tetanus (DPT), yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, and others. Hepatitis A is a disease caused by the hepatitis A virus (HAV), which results in inflammation of the liver. They are composed of mono vaccines and combination vaccines booked by online booking, in-person booking channels for domestic travel, and outbound travel applications.

What Is The Travel Vaccines Market Growth Forecast?

The travel vaccines market size is expected to see rapid growth in the next few years. It will grow to $8.16 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing global travel and mobility, advancements in biotechnology for combination vaccines, growth of digital health and telemedicine services, rising awareness of preventive healthcare, expansion of international travel immunization programs. Major trends in the forecast period include rise in international tourism and business travel, increasing awareness of preventive healthcare for travelers, expansion of online travel health services and booking platforms, development of combination and multivalent travel vaccines, growth in public-private partnerships for global immunization programs.

What Is The Driver Of The Travel Vaccines Market?

The increase in travel and tourism is expected to propel the growth of the travel vaccine market going forward. Travel and tourism refer to the movement of people or things, including vehicles like trains, boats, airplanes, and other conveyances, between various remote geographic areas. Travel vaccines are helpful for tourists and travelers by keeping them safe and healthy while they are traveling abroad. For instance, in May 2025, according to UN Tourism, a Spain-based specialized agency responsible for the promotion of responsible, sustainable, and universally accessible tourism, in the first three months of 2025, over 300 million tourists traveled internationally, about 14 million more than during the same period in 2024, which marks a 5% year-on-year increase. Therefore, the increase in travel and tourism is driving the growth of the travel vaccine industry.

How Will The Drivers Impact Growth In The Global Travel Vaccines Market?

• Rise In Outbound Tourism (High) – During the forecast period, the rise in outbound tourism is expected to become a key growth driver for the travel vaccines market by 2030. Increasing outbound tourism is driving the growth of the travel vaccines market by expanding the number of individuals visiting regions with higher risks of infectious diseases such as yellow fever, hepatitis, typhoid, and rabies. Rising international leisure travel, business travel, educational mobility, and adventure tourism are increasing awareness regarding preventive healthcare and mandatory vaccination requirements imposed by destination countries. Growing global connectivity and the recovery of international travel activities are further accelerating demand for travel immunization services and vaccine products worldwide. • Prevalence Of Hepatitis A Across Major Travel Destinations (High) – During the forecast period, the prevalence of hepatitis a across major travel destinations is expected to emerge as a major factor driving the expansion of the travel vaccines market by 2030. The prevalence of hepatitis A across major travel destinations is significantly driving the travel vaccines market as international travelers face increased exposure to contaminated food, water, and poor sanitation conditions in regions across Asia, Africa, Latin America, and parts of the Middle East. Growing awareness regarding travel-related infectious diseases and strong vaccination recommendations from organizations such as the CDC and WHO are increasing the adoption of hepatitis A vaccines before international travel. The rising number of travelers visiting endemic regions for tourism, business, education, and adventure activities is further accelerating demand for preventive immunization services globally. • Increasing Meetings, Incentives, Conferences, And Exhibitions (MICE) Activities (High) – During the forecast period, the increasing meetings, incentives, conferences, and exhibitions (MICE) activities is expected to act as a key growth catalyst for the travel vaccines market by 2030. Increasing Meetings, Incentives, Conferences, And Exhibitions (MICE) activities are driving the growth of the travel vaccines market by significantly increasing international business travel across multiple regions. The expansion of global corporate events, trade exhibitions, international conferences, and incentive travel programs is raising the number of travelers visiting countries with mandatory or recommended vaccination requirements. Growing cross-border business mobility and the recovery of the global events industry are further supporting demand for preventive immunization and travel health services worldwide.

How Will The Restraints Impact Growth In The Global Travel Vaccines Market?

• Lack Of Knowledge Among Travelers From Developing Nations (High) – During the forecast period, the lack of knowledge among travelers from developing nations acts as a restraint for the travel vaccines market by limiting awareness regarding travel-related infectious diseases, vaccination requirements, and preventive healthcare measures. Many travelers from low- and middle-income countries remain unaware of recommended immunization schedules for destinations with high risks of diseases such as yellow fever, hepatitis, typhoid, and meningitis. Limited access to travel health education, inadequate healthcare outreach, and lower consultation rates with travel clinics further reduce vaccine adoption and hinder overall market growth. • High Cost Of Travel Vaccination Programs (High) – During the forecast period, the high cost of travel vaccination programs restrains the growth of the travel vaccines market by increasing the financial burden associated with pre-travel immunization and healthcare consultations. Several travel vaccines require multiple doses, booster shots, and specialized medical guidance, which raises overall vaccination expenses for travelers. In developing and price-sensitive regions, limited insurance coverage and high out-of-pocket healthcare costs further discourage travelers from opting for recommended or mandatory travel immunization services. • Limited Access To Vaccination Centers In Remote Regions (High) – During the forecast period, the limited access to vaccination centers in remote regions restrains the growth of the travel vaccines market by reducing the availability of timely immunization services for travelers living in rural and underserved areas. Inadequate healthcare infrastructure, shortage of specialized travel clinics, and limited cold-chain distribution networks hinder the efficient delivery of travel vaccines across remote locations. These accessibility challenges often lead to lower vaccination coverage, delayed immunization, and reduced awareness regarding preventive travel healthcare measures.

Key Players In The Global Travel Vaccines Market

Major companies operating in the travel vaccines market are Pfizer Inc, Johnson and Johnson, Merck & Co. Inc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Bharat Biotech International Limited, Bio Farma, Novavax Inc, Emergent BioSolutions UK, Biological E. Limited, Vabiotech, Cadila Healthcare Limited, Zydus Lifesciences Ltd, Cipla Inc, Haffkine Biopharmaceutical Corporation Ltd

Global Travel Vaccines Market Trends and Insights

Major companies operating in the travel vaccine market are developing innovative vaccines to provide active immunization to prevent Hepatitis A common concern for travelers. A travel vaccine is a vaccine specifically designed to protect individuals from infectious diseases that are prevalent in certain regions or countries, often recommended for travelers visiting those areas. For instance, in January 2024, Indian Immunologicals Ltd. (IIL), an India-based biotechnology company, launched Havisure, India’s first indigenously developed Hepatitis A vaccine. Havisure is anticipated to be instrumental in providing protection against the Hepatitis A virus, which mainly impacts the liver. This vaccine is effective in preventing the disease and is advised for children as part of routine immunization. Additionally, it is recommended for individuals at risk of exposure or those traveling to areas with high rates of hepatitis A.

What Are Latest Mergers And Acquisitions In The Travel Vaccines Market?

In May 2023, Bavarian Nordic, a US-based biopharmaceutical company, acquired Emergent BioSolutions’ travel vaccine portfolio for an undisclosed amount. With the acquisition, Bavarian Nordic gained two commercially available vaccines-Vivotif for the prevention of typhoid fever and Vaxchora for the prevention of cholera, as well as a Phase 3 vaccine candidate for the prevention of the Chikungunya virus. The acquisition also includes US-based R&D facilities, a Swiss biologics production facility, and EU and US commercial operations with a specialized salesforce. Emergent BioSolutions is a US-based biotechnology firm that specializes in manufacturing and developing devices, vaccines, therapeutics, and contract manufacturing and travel vaccines is a business division of the company.

What Defines the Travel Vaccines Market?

The travel vaccine market consists of sales of vaccines for diseases such as Japanese encephalitis, tick-borne encephalitis, and tuberculosis (TB). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Travel Vaccines Market Report 2026?

The travel vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the travel vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.